[email protected] |

A Paradigm Shift in
Cancer Treatments

Technology

AI-Enhanced Treatment Insights

Up to 10 treatment options*, including Antibody-Drug Conjugates (ADCs), Immunotherapy, Targeted/Endocrine Therapy, and Chemotherapy, with justification for each drug in combinations, likely adverse events, contraindications, and precautions.

AI-Based Molecular Tumor Boards

Molecular tumor board briefing docket for case-specific analysis and decision-making support, ensuring the best possible clinical outcomes.

Video-Enhanced Insights

Video-enhanced insights from in-vitro chemotherapy effectiveness tests for Molecular Tumor Board review.

Exacta-Ai

Oncologists and Molecular Tumor Boards are facing an avalanche of new research, trial data, and molecular information which becomes humanly impossible to interpret and apply on a case-by-case basis. Exacta-Ai is an advanced process, powered by advanced composite intelligence, that delivers multiple therapy combinations customized to each patient’s profile, especially for those who have not responded to Standard of Care treatments. These options are rigorously evaluated for safety, side effects, and effectiveness, ensuring precision and personalized care. And there’s more.

Exacta-Ai

Oncologists and Molecular Tumor Boards are facing an avalanche of new research, trial data, and molecular information which becomes humanly impossible to interpret and apply on a case-by-case basis. Exacta-Ai is an advanced process, powered by advanced composite intelligence, that delivers multiple therapy combinations customized to each patient’s profile, especially for those who have not responded to Standard of Care treatments. These options are rigorously evaluated for safety, side effects, and effectiveness, ensuring precision and personalized care. And there’s more.

The Force Multipliers

Natural Intelligence (NI)

Natural Intelligence complements AI-based therapy guidance by integrating expert human insights and supervision. Skilled professionals with deep knowledge of cancer biology meticulously review and validate the AI-generated data, ensuring the highest level of accuracy and personalized solutions for patients with advanced cancer. This approach minimizes risks and enhances treatment effectiveness, providing patients with greater confidence in their care.

Emotional Intelligence (EI)

Emotional Intelligence is at the core of our commitment; we provide lifelong support by offering free Molecular Residual Disease (MRD) testing once every quarter, a breakthrough innovation which is indispensable for keeping a close watch on treatment response. This unwavering commitment reflects our continued support for the patient’s well-being.

Learn More

Smarter Risk Management

Smarter Risk Management

Our innovative platform provides oncologists with essential tools designed to elevate cancer care. From advanced diagnostics to tailored treatment plans, we prioritize the integration of AI technology into clinical workflows for enhanced patient outcomes. Our resources empower professionals to navigate the complexities of oncology with confidence and clarity.

Drug-Drug
Interaction Analysis
Contraindications For
Each Treatment Option
Toxicity Overlap /
Accumulation Analysis
Monitoring and Risk
Management Strategies

Leading Innovations in Oncology

Artificial Intelligence plays a crucial role in revolutionizing cancer care. By integrating advanced technology, we enhance treatment precision, aiming for superior patient outcomes in oncology.